Skip to main content
ARIX BIOSCIENCE PLC logo

ARIX BIOSCIENCE PLC — Investor Relations & Filings

Ticker · ARIX ISIN · GB00BD045071 LEI · 213800OVT3AHQCXNIX43 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2018-02-28 Regulatory Filings
Country GB United Kingdom
Listing IL ARIX

About ARIX BIOSCIENCE PLC

https://www.arixbioscience.com/

Arix Bioscience plc is a global venture capital company that specializes in the biotechnology and life sciences sectors. The firm's primary activity involves investing in and building innovative biotech companies, providing capital and strategic support from early stages, including seed, preclinical, and clinical development. Arix focuses on identifying and nurturing breakthrough advances in life sciences to accelerate the development of new medical technologies and therapies. According to public information, the company has entered into a process of liquidation.

Recent filings

Filing Released Lang Actions
Publication of a Prospectus
Regulatory Filings Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 2445G' and the closing signature 'This information is provided by RNS The company news service from the London Stock Exchange'). The core subject is the 'Publication of Prospectus' related to a 'proposed Firm Placing, Placing and Offer for Subscription (the "Capital Raising")'. Since the document is an announcement *about* the publication of a Prospectus (which details a capital raising/financing event) rather than the Prospectus itself, and it is a formal regulatory announcement, it fits best under the category for announcing the release of reports or general regulatory filings. Given the specific nature of announcing a Prospectus publication related to a capital raising, it is a strong candidate for Report Publication Announcement (RPA) or Capital/Financing Update (CAP). However, the primary action described is the *publication* of the Prospectus, which aligns perfectly with the definition of RPA: 'Announcement regarding the timing, release, or publication of company reports'. The content also heavily details the Capital Raising, which supports CAP. Since the document explicitly states 'Publication of Prospectus' and directs readers to the Prospectus for details on the Capital Raising, RPA is the most precise classification for this specific announcement type.
2018-02-28 English
Proposed Firm Placing, Placing and Offer
Capital/Financing Update Classification · 1% confidence The document is an RNS announcement (RNS Number : 1914G) dated February 28, 2018, detailing a 'Proposed Firm Placing, Placing and Offer for Subscription' to raise up to £100 million through the issue of new ordinary shares. It explicitly mentions the intention to publish a Prospectus and includes a 'Notice of General Meeting' conditional on the Capital Raising. This content directly relates to fundraising, share issuance, and capital structure changes. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it mentions a General Meeting, the primary focus is the capital raise itself, not the voting results (DVA) or the AGM materials (AGM-R). It is not a full 10-K or IR, but a specific announcement about a financing event.
2018-02-28 English
Publication of Prospectus
Capital/Financing Update Classification · 1% confidence The document explicitly identifies itself as a "PROSPECTUS" relating to a "Proposed Firm Placing of New Ordinary Shares" and an "Offer for Subscription of up to 20,000,002 New Ordinary Shares". It also contains a "Notice of General Meeting". A prospectus is a formal legal document required for offering securities to the public, often associated with a capital raising event. While it includes a notice for a General Meeting (suggesting AGM-R elements), the primary function and content structure (Risk Factors, Information on the Group, Capital Raising Statistics) align perfectly with documents detailing a public offering of shares. This is a core component of a financing activity. The most fitting category among the provided options for a document detailing a share offering/placing is 'Capital/Financing Update' (CAP). Although it is a full prospectus, the context of the offering makes CAP more specific than a general regulatory filing (RNS) or a simple AGM document.
2018-02-28 English
Arix Bioscience and Ipsen sign strategic agreement
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content describes a strategic agreement between Arix Bioscience Plc and Ipsen regarding the development and commercialization of therapies. This is a general corporate announcement released through the London Stock Exchange's Regulatory News Service (RNS). Since it is not a full financial report (like 10-K or IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate general regulatory announcement category is RNS.
2018-02-21 English
Arix signs strategic agreement with Fosun
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated February 19, 2018. The content describes a 'strategic agreement' between Arix Bioscience plc and Fosun International to develop and commercialize therapies. This is a corporate announcement regarding a significant business development (a partnership/agreement). It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a formal announcement disseminated via the RNS system, and it details a strategic business transaction that doesn't fit perfectly into CAP (financing) or TAR (M&A), the most appropriate general category for a significant, non-standard regulatory announcement distributed via RNS is 'Regulatory Filings' (RNS), as it serves as the catch-all for important news releases not covered by more specific codes. Given the nature of the announcement (strategic partnership), it could potentially be related to M&A (TAR) or Capital (CAP), but it is primarily a partnership announcement, making RNS the safest fit as a general regulatory news service release.
2018-02-19 English
CEO Letter to Shareholders
Board/Management Information Classification · 1% confidence The document is dated January 4, 2018, and is titled 'CEO Letter to Shareholders'. It reflects on the previous year (2017) and outlines expectations for the coming year (2018), discussing investments, scientific progress, and future milestones. This format—a direct communication from the CEO to shareholders summarizing performance and outlook—is characteristic of an Annual Report or a document closely related to it, such as a shareholder letter often included in or accompanying the Annual Report or an Investor Presentation. However, given the content is a reflective letter rather than a formal, structured financial statement (like a 10-K) or a detailed presentation deck (IP), and it is disseminated via RNS, it functions as a high-level summary and outlook. Since it is a comprehensive review of the past year's activities and future strategy, it aligns best with the spirit of an Annual Report (10-K) or a detailed Investor Presentation (IP). Because it is a letter format and not a formal regulatory filing like a 10-K, and it is clearly intended for investors summarizing the year, 'Investor Presentation' (IP) is a strong candidate, but 'Annual Report' (10-K) covers the comprehensive yearly review aspect. Given the context of a CEO letter summarizing the first full year post-IPO, it serves as the primary annual update for shareholders. If this were the actual 10-K, it would contain extensive audited financials, which are not present here. It reads more like a high-level summary/presentation of the year's achievements. Comparing it to the definitions, it is too detailed for a simple Earnings Release (ER) or Report Publication Announcement (RPA). It functions as a comprehensive annual update, making 'Investor Presentation' (IP) the most fitting category for this type of strategic, forward-looking shareholder communication, even though it's in letter format. The RNS number suggests it was released via the regulatory news service, but the content itself is an IP.
2018-01-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.